Scribd
Upload
3 views3 pages

Health Ass

Spatial epidemiology examines geographic variations in disease influenced by various risk factors and utilizes disease mapping to visualize health issues. Advances in data collection and analysis methods have improved the ability to study these variations, although challenges such as data quality and confidentiality remain. Environmental factors and access to healthcare significantly impact geographic health disparities, necessitating high-quality data for effective small-area studies.

Uploaded by

chalerabenjamin2
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
3 views3 pages

Health Ass

Spatial epidemiology examines geographic variations in disease influenced by various risk factors and utilizes disease mapping to visualize health issues. Advances in data collection and analysis methods have improved the ability to study these variations, although challenges such as data quality and confidentiality remain. Environmental factors and access to healthcare significantly impact geographic health disparities, necessitating high-quality data for effective small-area studies.

Uploaded by

chalerabenjamin2
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
You are on page 1/ 3

To begin with, Spatial epidemiology is the description and analysis of geographic variations

in disease with respect to demographic, environmental, behavioral, socioeconomic, genetic,


and infectious risk factors. We focus on small-area analyses, encompassing disease mapping,
geographic correlation studies, disease clusters, and clustering. Advances in geographic
information systems, statistical methodology, and availability of high-resolution,
geographically referenced health and environmental quality data have created unprecedented
new opportunities to investigate environmental and other factors in explaining local
geographic variations in disease. They also present new challenges. Problems include the
large random component that may predominate disease rates across small areas. Though this
can be dealt with appropriately using Bayesian statistics to provide smooth estimates of
disease risks, sensitivity to detect areas at high risk is limited when expected numbers of
cases are small. Potential biases and confounding, particularly due to socioeconomic factors,
and a detailed understanding of data quality are important. Data errors can result in large
apparent disease excess in a locality.

Lastly, disease mapping is the method of spatial epidemiology that is used to measure health
related issues. as noted earlier, disease maps have a long history. A survey in 1991 identified
49 international, national, and regional disease atlases. An early example was the work of
Stocks, who described variations in cancer mortality across counties of England and Wales.
More recent examples include an atlas of cancer incidence in England and Wales and an all-
causes mortality atlas and separate cancer mortality atlas for the United States. Disease maps
provide a rapid visual summary of complex geographic information and may identify subtle
patterns in the data that are missed in tabular presentations. They are used variously for
descriptive purposes, to generate hypotheses as to ethology, for surveillance to highlight areas
at apparently high risk, and to aid policy formation and resource allocation. They are also
useful to help place specific disease clusters and results of point-source studies in proper
context.

Disease maps typically show standardized mortality or morbidity (e.g., incidence) ratios
(SMRs) for geographic areas such as countries, counties, or districts. The rate in area i is
estimated by the standardized mortality (or morbidity) ratio (SMRi), calculated as Oi /Ei,
where Oi is the observed number of deaths or incident cases of disease in the area (assumed
to follow an independent Poisson distribution). Ei is the expected number of cases (calculated
by applying age- and sex-specific death or disease rates to population counts for the area).
The SMR thus defined is based on indirect standardization. Some authors advocate direct
standardization, as it involves adjustment to a common standard (Julious et al. 2001). In our
own experience, the two methods nearly always give near-identical results.

Investigation of disease clusters and disease incidence near a point source usually assumes
that the background risk surface is flat, against which a peak at the pollution source is being
tested. If this is not the case and the background surface is bumpy, that is, there are peaks and
troughs in the risk surface, this may indicate generalized or broad-scale clustering of the
disease. (Clearly in this situation, the observation of a disease excess at a particular point may
not be unusual.) This tendency for disease cases to occur in a nonrandom spatial pattern
relative to the pattern of the noncases has a more robust statistical formulation than the
investigation of disease clusters per se and may give clues as to etiology (Wakefield et al.
2000). For example, there is evidence of spatial clustering of Hodgkin disease (Alexander et
al. 1989) that, along with other epidemiologic and laboratory evidence, has suggested a
possible infectious etiology. The study of generalized clustering has much in common with
disease mapping, and the same cautionary considerations apply, particularly concerning the
quality of the underlying data.

Ecological correlation studies analyse associations between a set of variables defined on


aggregated groups of individuals. Within this class, geographical correlation studies are
particularly concerned with the joint variation or correlation of variables which represent
averages over geographically defined regions.

Environmental factors also contribute significantly to geographic correlations in health


issues. These include air quality, water quality, availability of green spaces, and exposure to
hazardous materials. Areas with high pollution levels may see increased respiratory illnesses
among residents compared to those living in cleaner environments. Research has shown that
environmental injustices often disproportionately affect marginalized communities, leading to
significant public health challenges.

Access to healthcare is another crucial element in measuring geographic correlations related


to health issues. Geographic barriers such as distance from healthcare facilities or lack of
transportation can hinder individuals from seeking necessary medical care. Studies have
demonstrated that populations living in rural areas often face greater challenges accessing
healthcare services than those in urban settings due to fewer available resources.

Challenges
Data Availability and Quality

To carry out small-area studies using routine data sources, the basic data need to be made
available, with high quality, and the inclusion of a geographically referenced code, such as
the postcode in the United Kingdom or the census block or block group in the United States.
Data should include (at the least) cancer registration as well as mortality, natality, and
population data. Although natality and mortality data are a statutory requirement in
developed countries, not all countries (including the United States) have a national cancer
registry, reducing the ability to carry out studies of environmental health problems. In the
United States, the Centers for Disease Control and Prevention (CDC) has established a
program in environmental public health tracking, one component of which funds states to
develop additional registries of health outcomes, such as asthma, for assessment of possible
environment.

Data Protection and Confidentiality

The current climate of legislation in the United States and the European Union is providing
greater recognition of the rights of individuals to confidentiality of personal data, including
health data, and the need for consent for medical investigations. In 2003, the United States
brought into force the Privacy Rule (Department of Health and Human Services 2002) arising
from the Health Insurance Portability and Accountability Act of 1996 (1996) that further
complicates this issue. This potentially impinges on the secondary use of routine data for
epidemiology (including spatial epidemiologic studies) where the data were originally
collected for other purposes (e.g., health care management or delivery), but consent for their
use for medical research is impracticable. In the United Kingdom, recent legislation has made
it possible to use such routinely collected data without consent if certain conditions and
safeguards are met. It is imperative for the future of epidemiologic research that such uses of
the data are allowed to continue, provided that appropriate safeguards are in place.

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy